On cell signalling mechanism of Mycobaterium leprae soluble antigen (MLSA) in Jurkat T cells

Molecular and Cellular Biochemistry

Volumn 287, Issue 1-2, 2006, Pages 157-164

  Joshi, Beenu ^a   Khedouci, Sihem ^b   Dagur, Pradeep Kumar ^a   Hichami, Aziz ^b   Sengupta, Utpal ^a   Khan, Naim Akhtar ^b  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Anergy; Ca2+; Leprosy; M. leprae soluble antigen; MAP kinase

Indexed keywords

BACTERIAL ANTIGEN; CALCIUM ION; CD3 ANTIBODY; INTERLEUKIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYCOBACTERIUM LEPRAE SOLUBLE ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE; RYANODINE RECEPTOR; THAPSIGARGIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL IMMUNITY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MYCOBACTERIUM LEPRAE; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, BACTERIAL; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; DOWN-REGULATION; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASES; MYCOBACTERIUM LEPRAE; PHOSPHORYLATION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 33745955122     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9132-8     Document Type: Article

References (30)

1. Smith W: We need to know what is happening to the incidence of leprosy. Lepr Rev 68: 195-200, 1997
2. World Health Organisation. Leprosy - Global situation. In: Weekly Epidemiol Rec 77: 1-8, 2002
3. Nath I, Singh R: The suppressive effect of M leprae on the in vitro proliferation responses of lymphocytes from patients with leprosy. Clin Exp Immunol 42: 203-210, 1980
4. Kaplan G, Cohn ZA: Cellular immunity in lepromatous and tuberculoid leprosy. Immunol Lett 11: 205-209, 1985
5. Koster FT, Scollard DM, Umland ET, Fishbein DB, Hanly WC, Brennan PJ, Nelson KE: Cellular and humoral immune response to a phenolic glycolipid antigen (Phen GL-1) in patients with leprosy. Clin Microbiol 25: 551-556, 1987
6. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279-282, 1991
7. Agrewala JN, Kumar B, Vohra H: Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy. Clin Exp Immunol 111: 56-63, 1998
8. Nath I, Vemuri N, Reddi AL, Jain S, Brooks P, Colston MJ, Misra RS, Ramesh V: The effect of antigen presenting cells on the cytokine profiles of stable and relational Lepromatous leprosy patients. Immunol Lett 75: 69-76, 2000
9. Grinstein S. Dixon SJ: Ion transport membrane potential, and cytoplasmic pH in lymphocytes: Changes during activation. Physiol Rev USA 69: 417-481, 1989
10. Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-299, 1994
11. Cantrell D: T cell antigen receptor signal transduction pathways. Annu Rev Immunol 14: 259-274, 1996
12. Lewis RS, Cahalan MD: Potassium and calcium channels in lymphocytes. Annu Rev Immunol 13: 623-653, 1995
13. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA. J Exp Med 173: 721-730. 1991
14. Ward GW: CD 28: A signalling perspective. J Biochem 318: 361-377, 1996
15. Sharma N, Sharma VK, Gupta A, Kaur I, Ganguly NK: Immunological defect in leprosy patients: Altered T-lymphocyte signals. FEMS Immunol Med Microbiol 23: 355-362, 1999
16. Sharma N, Sharma VK, Gupta A, Kaur I, Kaur S, Ganguly NK: Alteration in early biochemical events following T cell activation in leprosy patients. Clin Immunol Immunopathol 88: 142-149, 1998
17. Zea AH, Ochoa MT, Ghosh P, Longo DL, Alvord WG, Valderrama L, Falabella R, Harvey LK, Saravia N, Moreno LH, Ochoa AC: Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun. 66: 499-504, 1998
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985
19. Nel, AE, Hanekom C, Rheeder A, Williams K, Pollack S, Katz R, Landreth GE: Stimulation of MAP-2 kinase activity in T-lymphocytes by anti-CD3 or antiTCR monoclonal antibody is partially dependent on protein kinase C. J. Immunol. 144: 2683-2689, 1990
20. Tessier C, Hichami A, Khan NA: Implication of three isoforms of PLA(2) in human T-cell proliferation. FEBS Lett. 520: 111-116, 2002
21. Joshi B, Girdhar BK, Mohanty KK Beuria MK, Girdhar A, Sengupta U: Immunological profile of treated Lepromatous Leprosy patients. Int J Lep and Other Mycobac Dis 69: 195-203, 2001
22. Satish M, Bhutani LK, Sharma AK, Nath I: Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy. Infect Immun 42: 890-899, 1983
23. Kang SM, Beverly B, Tran AC, Brorson K, Schwartz RH, Lenardo MJ, Lenardo MJ: Translocation by AP-1 is a molecular target of T cell clonal anergy. Science 257: 1134-1138, 1992
24. 2+/calmodulin kinase. Nature 371: 347-350, 1994
25. Bonin A, Khan NA: Regulation of calcium signalling by docosahexaenoic acid in human T-cells: Implication of CRAC channels. J. Lipid Res. 41: 277-284, 2000
26. Denys A, Aires A, Hichami A, Khan NA: Thapsigargin phosphorylates MAP kinases by opening CRAC channels and PLD activation: Inhibitory action of docosahexaenoic acid. FEBS Lett. 564: 177-182, 2004
27. 2+ stores. Proc. Natl. Acad. Sci. USA. 90: 6295-6299, 1993
28. Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O'Keefe SJ, O'Neill EA: Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EMBO J. 13: 861-870, 1994
29. Fafutis-Morris M, Guillen-Vargas CM, Navarro-Fierros S, Alfaro-Bustamante F, Zaitzeva-Petrovna G, Daneri-Navarro A, Santoscoy-Tovar L, Armendariz-Borunda J: Addition of anti-CD28 antibodies restores PBMC proliferation and IFN gamma production in lepromatous leprosy patients. J Interferon Cytokine Res. 19: 1237-1243, 1999
30. Denys A, Hichami A, Khan NA: N-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J Lipid Res. 46: 752-758, 2005